Clinical Trial Detail

NCT ID NCT03383094
Title Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Loren Mell, MD
Indications

pharynx squamous cell carcinoma

oral squamous cell carcinoma

laryngeal squamous cell carcinoma

Therapies

Pembrolizumab

Cisplatin + Radiotherapy

Age Groups: adult senior

Additional content available in CKB BOOST